Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 11, 2016 8:28 AM ET

Capital Markets

Company Overview of Aisling Capital LLC

Company Overview

Aisling Capital LLC is a venture capital and private equity firm specializing in investments in seed and venture financings of development-stage, mid venture, growth capital, industry consolidations, product acquisitions, positioning companies in the public stock markets, and follow-on financings. The firm focuses on small-cap publicly traded equities, structured debt and royalty deals and large-cap leveraged buyouts. The firm seeks to invest in life sciences, healthcare products, services, and technologies. It typically invests in private and public healthcare companies, life science, companies developing pharmaceutical, biotechnology, medical products, alternative energy resources, and bus...

888 Seventh Avenue

12th Floor

New York, NY 10106

United States

Founded in 2000





Key Executives for Aisling Capital LLC

Founder and Senior Advisor
Age: 60
Chief Financial Officer and Chief Compliance Officer
Managing Partner
Age: 52
Managing Partner and Managing Director
Age: 50
Managing Partner
Age: 47
Compensation as of Fiscal Year 2015.

Aisling Capital LLC Key Developments

Aisling Capital Appoints Eric Aguiar as Partner

Aisling Capital has appointed Eric Aguiar, MD to the firm as a partner, bringing experience in drug development, commercialization and strategic leadership, to invest in biopharma opportunities across a range of therapeutic areas and stages of development. Prior to joining Aisling, Dr. Aguiar was a partner at Thomas, McNerney & Partners.

Aisling Capital LLC Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM

Aisling Capital LLC Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Dennis J. Purcell, Founder and Senior Advisor.

Aisling Capital Names Scott Braunstein, MD as an Operating Partner

Aisling Capital announced that Scott Braunstein, MD has joined the firm as an operating partner. Dr. Braunstein will assist in evaluating potential future investments for the firm, as well as working broadly with Aisling portfolio companies. Dr. Braunstein serves as Senior Vice President, Strategy and Corporate Development at Pacira Pharmaceuticals. He spent 12 years as a Healthcare Analyst and Portfolio Manager at J.P. Morgan Asset Management, where he invested in and conducted diligence on a wide variety of pharmaceutical products and product candidates. Dr. Braunstein serves as a director of Esperion Therapeutics, STAT Medical and the Cornell Alumni Association for the College of Agriculture and Life Sciences.

Similar Private Companies By Industry

Company Name Region
Brillhart Heskett Investments United States
Mobilestream Oil, Inc. Liquidating Trust United States
LeBow 2012 Nevada Trust United States
CapVal, LLC United States
Actavision Ventures, Inc. United States

Recent Private Companies Transactions

Private Placement
January 12, 2016
Syros Pharmaceuticals, Inc.
Private Placement
December 11, 2015
Pharmaron, Inc.
November 15, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aisling Capital LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at